Purpose The study aimed to provide a comprehensive bibliometric overview of the current
scientific publications on fibroblast activation protein inhibitor (FAPI) positron emission …

Simple Summary Non-small cell lung cancer treatment has undergone a revolution in the
past decade owing to the discovery of mutations that drive carcinogenesis and the …

Rationale: Early discovery, accurate diagnosis, and staging of lung cancer is essential for
patients to receive appropriate treatment. PET/CT has become increasingly recognized as a …

PET imaging that targets fibroblast activation protein (FAP) on the surface of cancer-
associated fibroblasts has yielded promising tumor diagnostic results. FAP-2286 contains …

Cancer cells are surrounded by a complex and highly dynamic tumor microenvironment
(TME). Cancer-associated fibroblasts (CAFs), a critical component of TME, contribute to …

Radiolabeled fibroblast activation protein (FAP) inhibitors (FAPIs) and Arg-Gly-Asp (RGD)
peptides have been extensively investigated for imaging of FAP-and integrin αvβ3–positive …

Purpose This study was designed to compare the performance of 68Ga-FAPI-04 and 18F-
FDG PET/CT for initial staging and recurrence detection of head and neck squamous cell …

FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging,
which have demonstrated several advantages over [18F] FDG, especially in the case of low …

This expedited systematic review aims to provide the first overview of the different Fibroblast
activation protein inhibitor (FAPI) PET scan procedures in the literature and discuss how to …

Purpose The purpose of this study is to compare the application value of 68Ga-FAPI and
18F-FDG PET/CT in primary and metastatic lesions of abdominal and pelvic malignancies …